Biosafet - 4 News from the business & finance department by Merck

Tip: You can further refine your news selection by countries.

Biosafet - 4 News from the business & finance department by Merck

Tip: You can further refine your news selection by countries.

image description

Merck Expands Newest Biologics Testing Center in Shanghai

Further develops its biosafety testing laboratories to meet local demand

23-Nov-2023 - Merck has completed the second phase of its new € 29 million Biologics Testing Center in China adding 1,500 square meters to the lab, which opened last year. These are the first biosafety laboratories for Merck in this market, enabling clients to locally access a broad range of testing services ...

biosafet biologics investments
image description

Merck Increases Global Commitment to Biosafety Testing With € 35 Million Investment in Scotland

Expansion creates nearly 500 new jobs in Glasgow and Stirling

02-Jun-2023 - Merck invests € 35 million in biosafety testing at its Glasgow and Stirling sites, Scotland. Biosafety testing is a critical step in the drug development and manufacturing process that ensures drugs are safe, efficacious, and meet regulatory requirements. The expansion will create nearly 500 new ...

biosafet drug design drug manufacturing
image description

Merck Invests € 290 Million in U.S. Drug Safety Testing Capacity

Responds to growing global demand for biosafety testing as essential requirement for drug development and commercialization

17-Nov-2022 - Merck invests more than €290million in its biosafety testing capacity at Rockville, Maryland, USA. This will significantly increase the company’s ability to conduct biosafety testing and analytical development services. Biosafety testing and analytical development are critical and fundamental ...

biosafet biosafety testing drug design
image description

Merck Announces Collaboration with Biotheus to Accelerate Drug Submission and Approval Process for Biopharmaceutical Industry in China

Reduces animal testing through molecular-based technology

08-Nov-2022 - Merck announced a collaboration with Biotheus, a China-based biotech company focused on developing treatments for cancer and autoimmune diseases. Utilizing Merck’s Blazar® Rodent Panel, Biotheus’ turn-around-time (TAT) of its cell line characterization reduced from around 60 days to 14 days. “The ...

biosafet animal experiments biologics

These products might interest you

Biosafety cabinet with integral Particle counter

Biosafety cabinet with integral Particle counter by TopAir Systems

The worlds first BSC with integral constant particle counting and contamination control

Innovative design from Polypropylene corrosion free and exceptional chemicals durability

safety cabinets
View product
Show all biosafet
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 27,214 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now